Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.
Department of General Surgery, AZ Sint Jan Brugge-Oostende, Bruges, Belgium.
Ann Surg. 2021 Nov 1;274(5):821-828. doi: 10.1097/SLA.0000000000005117.
To define "best possible" outcomes for secondary bariatric surgery (BS).
Management of poor response and of long-term complications after BS is complex and under-investigated. Indications and types of reoperations vary widely and postoperative complication rates are higher compared to primary BS.
Out of 44,884 BS performed in 18 high-volume centers from 4 continents between 06/2013-05/2019, 5,349 (12%) secondary BS cases were identified. Twenty-one outcome benchmarks were established in low-risk patients, defined as the 75th percentile of the median outcome values of centers. Benchmark cases had no previous laparotomy, diabetes, sleep apnea, cardiopathy, renal insufficiency, inflammatory bowel disease, immunosuppression, thromboembolic events, BMI> 50 kg/m2 or age> 65 years.
The benchmark cohort included 3143 cases, mainly females (85%), aged 43.8 ± 10 years, 8.4 ± 5.3 years after primary BS, with a BMI 35.2 ± 7 kg/m2. Main indications were insufficient weight loss (43%) and gastro-esophageal reflux disease/dysphagia (25%). 90-days postoperatively, 14.6% of benchmark patients presented ≥1 complication, mortality was 0.06% (n = 2). Significantly higher morbidity was observed in non-benchmark cases (OR 1.37) and after conversional/reversal or revisional procedures with gastrointestinal suture/stapling (OR 1.84). Benchmark cutoffs for conversional BS were ≤4.5% re-intervention, ≤8.3% re-operation 90-days postoperatively. At 2-years (IQR 1-3) 15.6% of benchmark patients required a reoperation.
Secondary BS is safe, although postoperative morbidity exceeds the established benchmarks for primary BS. The excess morbidity is due to an increased risk of gastrointestinal leakage and higher need for intensive care. The considerable rate of tertiary BS warrants expertise and future research to optimize the management of non-success after BS.
确定二次减重手术(BS)的“最佳”结果。
BS 后不良反应和长期并发症的处理复杂且研究不足。再手术的适应证和类型差异很大,术后并发症发生率高于初次 BS。
在 2013 年 6 月至 2019 年 5 月期间,在四大洲的 18 个高容量中心进行的 44884 例 BS 中,确定了 5349 例(12%)二次 BS 病例。在低风险患者中建立了 21 项结果基准,这些患者定义为中心中位数结果值的第 75 百分位。基准病例无既往剖腹手术、糖尿病、睡眠呼吸暂停、心脏病、肾功能不全、炎症性肠病、免疫抑制、血栓栓塞事件、BMI>50kg/m2 或年龄>65 岁。
基准队列包括 3143 例患者,主要为女性(85%),年龄 43.8±10 岁,距初次 BS 后 8.4±5.3 年,BMI 为 35.2±7kg/m2。主要适应证为体重减轻不足(43%)和胃食管反流病/吞咽困难(25%)。术后 90 天,14.6%的基准患者出现≥1 种并发症,死亡率为 0.06%(n=2)。在非基准病例中观察到显著更高的发病率(OR 1.37),并且在转换/逆转或胃肠道缝合/吻合的修订手术后(OR 1.84)。转换 BS 的基准截止值为≤4.5%的再干预、术后 90 天≤8.3%的再手术。在 2 年(IQR 1-3)时,15.6%的基准患者需要再次手术。
二次 BS 是安全的,尽管术后发病率超过了初次 BS 的既定基准。发病率增加是由于胃肠道漏的风险增加和对重症监护的更高需求。大量需要三次 BS 手术表明需要专业知识和未来的研究来优化 BS 后失败的管理。